| 标题 |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Respir Med 作者:Wu YL, Cheng Y, Zhou J, Lu S, Zhang Y, Zhao J, Kim DW, Soo RA, Kim SW, Pan H, Chen YM, Chian CF, Liu X, Tan DSW, Bruns R, Straub J, Johne A, Scheele J, Park K, Yang JC, INSIGHT Investigators 出版日期:2020-05-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)